Chinook Therapeutics Inc Cvr (ADRO)
R&D Expenses
$51.30M
TTM · Period ending: · USD
ADRO R&D Expenses
Latest reported$51.30Mperiod ending
Latest reported$51.30Mperiod ending
ADRO TTM R&D Expenses ($26.64M → $51.30M)
TTM R&D Expenses
High-resolution chart · PNG
ADRO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 51,297,000 | |
| 57,575,000 | |
| 63,343,000 | |
| 67,045,000 | |
| 69,529,000 | |
| 72,694,000 | |
| 75,238,000 | |
| 75,836,000 | |
| 81,141,000 | |
| 86,920,000 | |
| 88,940,000 | |
| 89,384,000 | |
| 87,329,000 | |
| 81,921,000 | |
| 87,363,000 | |
| 87,718,000 | |
| 89,512,000 | |
| 82,279,000 | |
| 68,930,000 | |
| 58,649,000 | |
| 41,850,000 | |
| 35,440,000 | |
| 26,636,000 |